MapLight Therapeutics (MPLT) PT Raised to $36 at Stifel Jun 1, 2026 04:13PM
UBS Starts MapLight Therapeutics (MPLT) at Buy May 26, 2026 04:15PM
Craig-Hallum Starts MapLight Therapeutics (MPLT) at Buy May 21, 2026 10:10AM
MapLight Therapeutics, Inc. (MPLT) Misses Q1 EPS by 42c May 15, 2026 06:03AM
Needham Starts MapLight Therapeutics (MPLT) at Buy Apr 8, 2026 05:21AM


Apr 7, 2026 05:29AM TD Cowen Starts MapLight Therapeutics (MPLT) at Buy
Mar 26, 2026 12:15PM Stifel stays Buy rated on MapLight Therapeutics (MPLT) after in-line Q4 update
Mar 19, 2026 05:12AM Canaccord Starts MapLight Therapeutics (MPLT) at Buy
Jan 5, 2026 07:03AM MapLight Therapeutics gets FDA fast track status for Alzheimer's drug
Dec 3, 2025 10:44AM Jefferies on MapLight Therapeutics (MPLT): 'Cleaner Catalyst Flow as Competitor Pushes Back Alz Psychosis Data to YE:26'
Nov 21, 2025 06:20AM Leerink Partners Starts MapLight Therapeutics (MPLT) at Outperform
Nov 21, 2025 01:07AM Jefferies Starts MapLight Therapeutics (MPLT) at Buy
Nov 21, 2025 01:06AM Stifel Starts MapLight Therapeutics (MPLT) at Buy
Nov 21, 2025 12:57AM Morgan Stanley Starts MapLight Therapeutics (MPLT) at Overweight
Oct 23, 2025 11:52AM MapLight (MPLT) reportedly to stop taking IPO orders at noon Thursday
Oct 20, 2025 10:53AM MapLight Therapeutics IPO reportedly well oversubscribed
Oct 6, 2025 04:11PM MapLight Therapeutics files for 14.75M share IPO at $17/sh
Sep 19, 2025 04:15PM MapLight (MPLT) files for proposed Nasdaq IPO